Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Romanato, M.
Right arrow Articles by Calvo, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romanato, M.
Right arrow Articles by Calvo, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 18, No. 9, 1868-1873, September 2003
© 2003 European Society of Human Reproduction and Embryology

Heparan sulphate: a putative decondensing agent for human spermatozoa in vivo

Marina Romanato1, Mónica S. Cameo1, Gabriel Bertolesi3, Consuelo Baldini1, Juan Carlos Calvo2,3 and Lucrecia Calvo1,4

1 Biología de la Reproducción, 2 Instituto de Biología y Medicina Experimental and 3 Department of Biological Chemistry, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina

4 To whom correspondence should be addressed. e-mail: lucrecalvo{at}fibertel.com.ar

BACKGROUND: Human sperm decondense in vitro upon exposure to heparin and glutathione. The aim of this study was to evaluate whether this decondensing ability of heparin in vitro is related to structural characteristics of the molecule and to test the in-vitro decondensing ability of other glycosaminoglycans. METHODS: Capacitated sperm obtained from normospermic semen samples were decondensed in the presence of heparin (or its equivalent) and glutathione. After fixation with glutaraldehyde, the percentage of decondensed sperm was determined under phase contrast. RESULTS: The decondensing ability of heparin was related to sulphation characteristics of the molecule: heparin, O-desulphated heparin and N-desulphated-N-acetylated heparin had similar decondensing abilities; N-desulphated was less active and O/N-desulphated-N-acetylated heparin was completely inactive. On the other hand, the decondensing ability of heparin was not affected by molecular weight, within the range 3000–18 000 kDa. When the decondensing ability of different glycosaminoglycans was tested, heparin and heparin sulphate were equally active, while chondroitin sulphate and hyaluronic acid were completely inactive and dermatan sulphate was slightly active. CONCLUSIONS: Our results indicate that heparin’s decondensing ability in vitro is related to sulphation characteristics of the molecule and suggest that heparan sulphate, a structural analogue of heparin, could be a sperm-decondensing agent in vivo.

Key words: fertilization/gamete biology/sperm


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
M. Romanato, V. Julianelli, M. Zappi, L. Calvo, and J.C. Calvo
The presence of heparan sulfate in the mammalian oocyte provides a clue to human sperm nuclear decondensation in vivo
Hum. Reprod., May 1, 2008; 23(5): 1145 - 1150.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
O. Mudrak, N. Tomilin, and A. Zalensky
Chromosome architecture in the decondensing human sperm nucleus
J. Cell Sci., October 1, 2005; 118(19): 4541 - 4550.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Romanato, E. Regueira, M. S. Cameo, C. Baldini, L. Calvo, and J. C. Calvo
Further evidence on the role of heparan sulfate as protamine acceptor during the decondensation of human spermatozoa
Hum. Reprod., October 1, 2005; 20(10): 2784 - 2789.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.